Johnson & Johnson has reached an agreement with the Trump administration to cut drug prices in the U.S. in exchange for exemption from Trump’s tariffs. In a statement this week, the pharmaceutical giant said as part of the agreement, Johnson & Johnson will participate in the planned website TrumpRx.gov, “which will allow millions of American patients to purchase medicines from Johnson & Johnson at significantly discounted rates.” The company also announced two new U.S. manufacturing facilities under construction, one in Pennsylvania and one in North Carolina. The county or town of the new facility to be built here in Pennsylvania has not yet been revealed.
Menu
